Envoy Medical (COCH) Shares Outstanding (Weighted Average) (2020 - 2026)

Envoy Medical has disclosed Shares Outstanding (Weighted Average) across 7 years of filings, most recently posting $68.9 million for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $68.9 million, up 223.23% year-over-year; the trailing twelve-month figure through Mar 2026 was $68.9 million (up 223.23% YoY), and the FY2025 annual result was $23.3 million, up 23.78% from the prior year.
• Shares Outstanding (Weighted Average) came in at $68.9 million for Q1 2026 at Envoy Medical, up from $2.1 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $68.9 million in Q1 2026 to a low of $664883.0 in Q4 2024.
• The 5-year median for Shares Outstanding (Weighted Average) is $18.6 million (2024), against an average of $20.0 million.
• Across the five-year window, Shares Outstanding (Weighted Average) surged 304.76% in 2022 and slumped 94.59% in 2024, its largest moves.
• Envoy Medical's Shares Outstanding (Weighted Average) stood at $10.1 million in 2022, then advanced by 21.46% to $12.3 million in 2023, then plunged by 94.59% to $664883.0 in 2024, then jumped by 211.94% to $2.1 million in 2025, then jumped by 3223.75% to $68.9 million in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $68.9 million (Q1 2026), $2.1 million (Q4 2025), and $21.9 million (Q3 2025), per Business Quant data.